Inogen (INGN) Change in Accured Expenses (2013 - 2026)
Inogen (INGN) reported Change in Accured Expenses of -$400000.0 for Q1 2026, down 105.81% year-over-year from $6.9 million in Q1 2025, and down 2122.22% quarter-over-quarter from -$18000.0 in Q4 2025.
Inogen (INGN) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Change in Accured Expenses data on file, last reported at -$400000.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$400000.0, down 105.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 112.47% YoY), and the FY2025 annual result was $5.6 million, down 10.03% from the prior year.
- Change in Accured Expenses fell to -$400000.0 in Q1 2026 per INGN's latest filing, from -$18000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $9.2 million in Q4 2024 and troughed at -$13.4 million in Q4 2022.
- A 5-year average of $282705.9 and a median of -$18000.0 in 2025 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses tumbled 3819.23% in 2024, then soared 1634.3% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$13.4 million in 2022, then jumped by 119.99% to $2.7 million in 2023, then soared by 243.28% to $9.2 million in 2024, then tumbled by 100.2% to -$18000.0 in 2025, then slumped by 2122.22% to -$400000.0 in 2026.
- Business Quant data shows INGN's Change in Accured Expenses at -$400000.0 in Q1 2026, -$18000.0 in Q4 2025, and $4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Inogen | 174.59 Mn | 80.18 Mn | 37.86 Mn | -400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -400,000.00 |
| Mar 31, 2026 | -400,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 403,000.00 |
| Sep 30, 2024 | 403,000.00 |
| Jun 30, 2024 | -2.90 Mn |
| Jun 30, 2024 | -2.90 Mn |
| Mar 31, 2024 | -449,000.00 |
| Mar 31, 2024 | -449,000.00 |
| Dec 31, 2023 | 2.67 Mn |
| Dec 31, 2023 | 2.67 Mn |